GoodRx
GDRX
$6.69
Share price
-0.59%
Change (1 day)
14.75%
Change (1 year)
Categories
GoodRx (GDRX) - Cash on Hand
Cash on Hand as of December 2023 : $0.67 B
According to GoodRx's latest financial reports the company has $0.67 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
GoodRx - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.67 B | -11.21% |
| 2022-12-31 | $0.75 B | -19.55% |
| 2021-12-31 | $0.94 B | -2.85% |
| 2020-12-31 | $0.96 B | 3618.58% |
| 2019-12-31 | $26.05 M | -24.71% |
| 2018-12-31 | $34.6 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Perion Network PERI | $0.52 B | -22.11% | 🇮🇱 Israel |